• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cytosorbents Cor (NQ: CTSO )

    1.070 -0.010 (-0.93%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 13,114
    Open 1.070
    Bid (Size) 1.030 (8)
    Ask (Size) 1.100 (2)
    Prev. Close 1.080
    Today's Range 1.030 - 1.080
    52wk Range 0.7000 - 2.665
    Shares Outstanding 54,429,617
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From CytoSorbents
    Via GlobeNewswire
    CTSO Stock Earnings: CytoSorbents Beats EPS, Beats Revenue for Q2 2024
    CTSO stock results show that CytoSorbents beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    N/A
    N/A
    1 Month
    -11.57%
    -11.57%
    3 Month
    +24.13%
    +24.13%
    6 Month
    +8.76%
    +8.76%
    1 Year
    -56.85%
    -56.85%

    More News

    Read More
    CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
    From CytoSorbents
    Via GlobeNewswire
    Recap: CytoSorbents Q4 Earnings
    Via Benzinga
    A Preview Of CytoSorbents's Earnings
    Via Benzinga
    CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
    From CytoSorbents
    Via GlobeNewswire
    Why CytoSorbents (CTSO) Stock Is Trading Higher
    Via Benzinga
    CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Secures $20 Million Credit Facility
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
    From CytoSorbents
    Via GlobeNewswire
    CTSO Stock Earnings: CytoSorbents Meets EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    CytoSorbents Reports First Quarter 2024 Results
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents to Report First Quarter 2024 Operating and Financial Results
    From CytoSorbents
    Via GlobeNewswire
    STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
    From CytoSorbents
    Via GlobeNewswire
    CTSO Stock Earnings: CytoSorbents Beats EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
    From CytoSorbents
    Via GlobeNewswire
    Earnings Scheduled For March 14, 2024
    Via Benzinga
    CytoSorbents to Report Fiscal 2023 Operating and Financial Results
    From CytoSorbents
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.